Executive Director, US Brand Lead, Neurology
SeniorCommercialRare Diseases
From $302K/yr(estimated)
Description
<div class="content-intro"><div><strong>Why Join Us?</strong></div>
<div>&nbsp;</div>
<div><em>Be a hero for our rare disease patients</em></div>
<div><em>&nbsp;</em></div>
<div>At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do.&nbsp;To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.&nbsp;</div>
<div>&nbsp;</div>
<div>Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work.&nbsp;Ultimately, we want to be an organization where we would be proud for our family, friends and children to work.</div>
<div>&nbsp;</div>
<div>If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and&nbsp;personally, come join our team<em>. </em></div></div><h3 style="text-align: left;"><strong>Position Summary:</strong></h3>
<p style="text-align: left;"><em><strong>ultra</strong>dedicated – Your biggest challenges yield rare possibilities</em></p>
<p style="text-align: left;"><span class="TextRun SCXW64085190 BCX0" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW64085190 BCX0">Ultragenyx is preparing for the potential commercialization of a rare disease </span><span class="NormalTextRun SCXW64085190 BCX0">Antisense oligonucleotide</span><span class="NormalTextRun SCXW64085190 BCX0"> therapy for the treatment of </span><span class="NormalTextRun SCXW64085190 BCX0">Angelman S</span><span class="NormalTextRun SCXW64085190 BCX0">yndrome</span><span class="NormalTextRun SCXW64085190 BCX0">.</span><span class="NormalTextRun SCXW64085190 BCX0">&nbsp; </span><span class="NormalTextRun SCXW64085190 BCX0">The Executive Directo</span><span class="NormalTextRun SCXW64085190 BCX0">r</span><span class="NormalTextRun SCXW64085190 BCX0">, US </span><span class="NormalTextRun SCXW64085190 BCX0">Brand Lead</span><span class="NormalTextRun SCXW64085190 BCX0">, </span><span class="NormalTextRun SCXW64085190 BCX0">Neurology</span> <span class="NormalTextRun SCXW64085190 BCX0">Therapeutic Area</span><span class="NormalTextRun SCXW64085190 BCX0"> will</span><span class="NormalTextRun SCXW64085190 BCX0"> lead the </span><span class="NormalTextRun SCXW64085190 BCX0">US </span><span class="NormalTextRun SCXW64085190 BCX0">launch</span><span class="NormalTextRun SCXW64085190 BCX0"> with accountability for pre-launch</span><span class="NormalTextRun SCXW64085190 BCX0"> activities and execution of commercial launch</span><span class="NormalTextRun SCXW64085190 BCX0">.&nbsp; </span><span class="NormalTextRun SCXW64085190 BCX0">Candidates must have </span><span class="NormalTextRun SCXW64085190 BCX0">a track record</span><span class="NormalTextRun SCXW64085190 BCX0"> of b</span><span class="NormalTextRun SCXW64085190 BCX0">uil</span><span class="NormalTextRun SCXW64085190 BCX0">ding</span><span class="NormalTextRun SCXW64085190 BCX0"> a blockbuster rare disease, neurology, pediatric and adult break through treatment seeing through from launch to peak year growth</span><span class="NormalTextRun SCXW64085190 BCX0">.</span><span class="NormalTextRun SCXW64085190 BCX0">&nbsp; </span></span><span class="TextRun SCXW64085190 BCX0" lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW64085190 BCX0">The role will report to the SVP, Head of North America Region</span><span class="NormalTextRun SCXW64085190 BCX0">, Commercial Operations.</span></span><span class="EOP SCXW64085190 BCX0" data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559740&quot;:256}">&nbsp;</span></p>
<h3 style="text-align: left;"><strong>Work Model:&nbsp;</strong></h3>
<p style="text-align: left;"><span class="TextRun Underlined SCXW179329379 BCX0" lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW179329379 BCX0">Field:</span></span><span class="TextRun SCXW179329379 BCX0" lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW179329379 BCX0"> Officially documented as working as a member of the Ultragenyx field team, generally interacting with third parties on behalf of Ultragenyx.</span></span><span class="EOP SCXW179329379 BCX0" data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:120,&quot;335559740&quot;:240}">&nbsp;</span></p>
<h3 style="text-align: left;"><strong>Responsibilities:</strong></h3>
<ol>
<li style="line-height: 2;"><span data-contrast="auto">Lead the creation and execution of North America Brand Strategy for GTX 102 for the treatment of Angelman Syndrome in collaboration with cross functional partners and global brand strategy.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Co-Lead cross-functional US launch team for GTX-102 across Sales, Marketing, Medical Affairs, Market Access, Patient Services, Channel Operations, Supply Chain, &amp; Patient Advocacy.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Drive alignment and decision-making among senior stakeholders ensuring launch plans are refined and organizational readiness in place for an exceptional US launch.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Build US disease awareness &amp; brand campaigns including HCP, Patient, and Digital strategy for the brand.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Develop and execute GTX-102 brand strategy and US go-to-market strategy ensuring an exceptional launch for a potential blockbuster breakthrough rare disease therapy.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Hire &amp; lead exceptional neurology team with high patient focus and strong understanding of rare disease commercialization.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
</ol>
<h3 style="text-align: left;"><strong>Requirements:</strong></h3>
<ol>
<li style="line-height: 2;"><span data-contrast="auto">15+ years biopharmaceutical experience with multiple rare disease launch experience in the US with a focus on pediatric and adult rare diseases.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Strong understanding of US rare disease commercialization models including complexities in treatment pathways and unique product to patient models.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Developed innovative and compliant approaches to identify and treat appropriate rare disease patients with a sense of urgency, purpose, and compassion.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Strong understanding of US healthcare system, reimbursement, product to patient models.&nbsp;</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Launched scientifically complex treatments from hospital administered &amp; buy &amp; bill models.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Leader with experience in competitive therapeutic areas and demonstrated successful positioning of brands.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Excellent verbal and written communication skills and ability to work and influence in a matrix environment.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Outstanding leadership and interpersonal skills driving projects from planning to implementation, while promoting teamwork between departments.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Takes proactive leadership to support company strategies enrolling leaders and individuals to execute plans in a motivating and respectful manner.&nbsp;</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Embraces change, challenges the status quo, and makes recommendations for improvements to products and processes.&nbsp;</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Strong ability to work with ambiguity and simplify complex processes into operational processes without creating overly burden processes.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Strong ability to maintain confidentiality as will be exposed to management discussions, confidential material, and strategies in their formative stages.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
<li style="line-height: 2;"><span data-contrast="auto">Approximately 30% travel as needed.</span><span data-ccp-props="{&quot;201341983&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:200,&quot;335559740&quot;:276}">&nbsp;</span></li>
</ol>
<p><span style="color: rgb(255, 255, 255);"><em>#LI-AM1 </em><em><span class="ui-provider dir dis c d e f g h i j k l m n o p q r s t dit diu w x y z ab ac ae af ag ah ai aj ak">#LI-Remote</span></em></span></p><div class="content-pay-transparency"><div class="pay-input"><div class="description"><p><em>The typical annual salary range for this full-time position is listed below. This range reflects the characteristics of the job, such as required skills and qualifications and is based on the office location noted in this job posting. The range may also be adjusted based on applicant's geographic location.</em></p>
<p><em><br>This position is eligible for annual bonus and equity incentives. Actual individual pay is determined by demonstrated experience and internal equity alignment.</em></p></div><div class="title">Pay Range</div><div class="pay-range"><span>$301,800</span><span class="divider">&mdash;</span><span>$372,800 USD</span></div></div></div><div class="content-conclusion"><div>&nbsp;</div>
<div><strong><em>Full Time employees across the globe enjoy a range of benefits, including, but not limited to:</em></strong></div>
<div>&nbsp;</div>
<div><strong><em>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generous vacation time and public holidays observed by the company</em></strong></div>
<div><strong><em>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Volunteer days</em></strong></div>
<div><strong><em>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Long term incentive and Employee stock purchase plans or equivalent offerings</em></strong></div>
<div><strong><em>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Employee wellbeing benefits</em></strong></div>
<div><strong><em>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fitness reimbursement</em></strong></div>
<div><strong><em>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tuition sponsoring</em></strong></div>
<div><strong><em>·&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Professional development plans</em></strong></div>
<div>&nbsp;</div>
<div><em>* Benefits vary by region and country</em></div>
<div>
<p><strong>Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at </strong><a href="mailto:talentacquisition@ultragenyx.com"><strong>talentacquisition@ultragenyx.com</strong></a><strong>.</strong></p>
</div>
<div><em>See our&nbsp;</em><a class="postings-link" href="https://www.ultragenyx.com/CCPA-Notice/"><em>CCPA Employee and Applicant Privacy Notice</em></a><em>.</em></div>
<div><em>See our&nbsp;</em><a class="postings-link" href="https://www.ultragenyx.com/privacy-policy/">Privacy Policy</a><em>.</em></div>
<div>
<p><strong>It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.</strong></p>
</div>
<div><strong>Note to External Recruiters</strong>: All candidate activity and open positions are managed strictly through our Human Resources Department. Our Human Resources Department kindly requests that recruiters not contact employees/hiring managers directly in an attempt to solicit business and present candidates. Please note that failure to comply with this request will be a factor in determining a professional relationship with our organization. Submission of unsolicited resumes prior to an agreement set in place between the Human Resources Department and the recruiting agency will not create any implied obligation. &nbsp;Inquiries on developing a recruiting relationship with us, may be directed to<em>:&nbsp;</em><a class="postings-link" href="http://mailto:talentacquisition@ultragenyx.com/">talentacquisition@ultragenyx.com</a><em>.</em></div></div>
Ultragenyx Pharmaceutical
PHARMACEUTICAL
Small Molecules, Biologics
LocationNOVATO, CA
Open Jobs28
Rare DiseasesMetabolic DiseasesNeurologyOphthalmologyNephrology
View Company ProfilePipeline
Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab AN/A
No InterventionN/A
No interventionN/A
Adeno-Associated Virus (AAV) Antibody Study in Subjects OTC Deficiency, GSDIa, and Wilson DiseaseN/A
Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CTN/A